AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) and Astellas Pharma Inc. (YPH.BE) Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting
5/16/2013 8:42:33 AM
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Hit With Flurry of Class Action Lawsuits
5/13/2013 8:30:47 AM
More...
|
FDA Committee Turns Down AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO)/Astellas Pharma Inc. (YPH.BE)'s Cancer Drug
5/3/2013 7:41:57 AM
More...
|
FDA Staff Says AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Kidney Cancer Drug May Need More Study
4/30/2013 8:02:42 AM
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Reports First Quarter 2013 Financial Results
4/29/2013 6:27:15 AM
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) to Present at the Barclays Global Healthcare Conference
3/6/2013 6:20:08 AM
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) to Present at the 2013 RBC Capital Markets’ Healthcare Conference
2/20/2013 6:13:24 AM
More...
|
Astellas Pharma Inc. (YPH.BE) and AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Report Positive Kidney Cancer Drug Trial Data
2/13/2013 6:45:44 AM
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Reports 2012 Financial Results and Highlights Recent Accomplishments
2/13/2013 6:22:53 AM
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Conference Call
1/31/2013 6:17:26 AM
More...
|
|